Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/15/2003WO2003040168A2 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
05/15/2003WO2003040100A1 Compositions, methods and kits pertaining to luminescent compounds
05/15/2003WO2003040089A1 Thiols and disulphides and their use in producing substrates
05/15/2003WO2003040064A2 Kits and methods for preparing cell samples optimized for dual staining
05/15/2003WO2003040025A1 Micrograin film and process for producing the same
05/15/2003WO2003040024A2 Assay based on doped nanoparticles
05/15/2003WO2003039759A1 Immobilizing device
05/15/2003WO2003039703A2 Method in the form of a dry rapid test for detecting nucleic acids
05/15/2003WO2003039702A2 Methods and compositions for chromatography
05/15/2003WO2003039576A1 Psp-94: use for treatment of hypercalcemia and bone metastasis
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039572A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003WO2003039490A2 Compositions and methods for diagnosing and treating mental disorders
05/15/2003WO2003039484A2 Novel compositions and methods for cancer
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039443A2 Novel genetic markers for leukemias
05/15/2003WO2003039441A2 Unc-13 in the modulation of neurotransmission and secretion events
05/15/2003WO2003039362A1 Reagent-less whole-blood glucose meter
05/15/2003WO2003039349A2 Method of using physiological markers to estimate cardiovascular risk
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2003039341A2 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804
05/15/2003WO2003039327A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
05/15/2003WO2003039242A1 A method and a device for determination of the actual photosynthesis in plants
05/15/2003WO2003039234A2 Pharmacogenomics-based system for clinical applications
05/15/2003WO2003039230A2 Sample well strip
05/15/2003WO2003002976A3 Methods and reagents for detecting endotoxin
05/15/2003WO2003001976A3 A secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
05/15/2003WO2003001199A3 Determination of in-mouth sensory properties of foodstuffs
05/15/2003WO2002103353A3 Threshold glucose detection in urine
05/15/2003WO2002101359A3 Integrated blood sampling analysis system with multi-use sampling module
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002096266A3 Method and system for optically performing an assay to determine a medical condition
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003WO2002075316A3 Method of detecting amyloid-containing lesions by autofluorescence
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003WO2002063001A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/15/2003WO2002061429A8 A label-free high-throughput optical technique for detecting biomolecular interactions
05/15/2003WO2002061148A3 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
05/15/2003WO2002061130A3 Methods and reagents for analysis of rna structure and function
05/15/2003WO2002059608A3 Compositions and methods related to chemokine (c motif) xc receptor 1 (ccxcr1)
05/15/2003WO2002058679A3 Antiangiogenic compounds and an assay for inhibitors of cell invasion
05/15/2003WO2002057451A9 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
05/15/2003WO2002057020A3 Rotor core for blood processing apparatus
05/15/2003WO2002056027A3 Regulation of neutral development by daedalos
05/15/2003WO2002055728A3 Compositions and methods for regulating receptor clustering
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002048398A3 In situ hybridization system for specifically detecting microorganisms
05/15/2003WO2002048366A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002048365A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002044737A3 Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor
05/15/2003WO2002041784B1 Allergy test chamber
05/15/2003WO2002041002A3 Discordant helix stabilization for prevention of amyloid formation
05/15/2003WO2002040716A3 Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
05/15/2003WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01
05/15/2003WO2002035241A3 High throughput screening for protein formulations
05/15/2003WO2002033732A9 Sensors comprising a semi-conductive polymer
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002029031A3 Isoprenoid-dependent ras anchorage (idra) proteins
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003WO2002016952A3 Detecting polymers and polymer fragments
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003WO2001096025A3 Systems and methods for cell subpopulation analysis
05/15/2003WO2001071309A3 Methods and reagents for regulation of cellular responses in biological systems
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
05/15/2003US20030093241 Method of evaluating logs to predict properties of lumber or veneer produced from the logs
05/15/2003US20030093227 Statistical combining of cell expression profiles
05/15/2003US20030093226 Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
05/15/2003US20030093225 Method for reducing noise in analytical assays
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092893 Antibody for use in the diagnosis of cancer, reproductive, kidney and nervous system disorders
05/15/2003US20030092892 Crosslinking, agglutination, purification
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092885 Solubility and stability enhancement tag for structural and ligand binding studies of proteins
05/15/2003US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders
05/15/2003US20030092752 Medical diagnosis; complexing with label
05/15/2003US20030092730 Glutamate receptor antagonist
05/15/2003US20030092686 Calibrating therapy dosage
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092631 IGF antagonist peptides
05/15/2003US20030092629 Inhibitors of memapsin 2 and use thereof
05/15/2003US20030092626 Use in drug screening, diagnosis, prophylaxis and treatment of central dysfunction, inflammatory diseases, cardiovascular disorders, diabetes, immune system disorders or gastrointestinal disorders
05/15/2003US20030092623 Inducing proliferation of endothelial cells; use of Bv8 antagonists to treat testicular cancer and hormone dependent tumors; Bv8 is a small protein originally isolated from the skin secretions of the frog Bombina variegata
05/15/2003US20030092619 Determining whether a substance can modulate the interaction of STAT6 (signal transducer and activator of transcription 6) with NCoA-1,(nuclear coactivator); drug screening; Hodgkin Lymphomas, asthma
05/15/2003US20030092614 Protein isoform related to sideroflexin 1, named ADPI-41, Alzheimer's disease-Associated Protein Isoform (ADPI); vectors, host cells, antibodies, vaccines; use in the diagnosis, screening, treatment and prophylaxis of AD
05/15/2003US20030092605 Modulators of leukocyte activation, compositions and methods of use
05/15/2003US20030092603 Identification of specific modulators of bone formation
05/15/2003US20030092601 Microcompetition and human disease
05/15/2003US20030092393 Remote sampling system
05/15/2003US20030092201 Particles for immunoassays and methods for treating the same
05/15/2003US20030092200 Agglutination assay method in porous medium layer
05/15/2003US20030092199 Detection of viral disease in animal carcasses; terminate animal, remove tissue sample, homogenize tissue, expose to enzyme, incubate with antibody, detect viral disease
05/15/2003US20030092198 Site-specific labeling of disulfide-containing targeting vectors
05/15/2003US20030092197 Monitoring heart activity; obtain fluid sammple, analyze, compare to control, classify heart activity
05/15/2003US20030092194 Apparatus for use for detection, analysis and measurement of fluorescent signal from sample
05/15/2003US20030092192 Apparatus for detection of combustion gas in the coolant of an internal combustion engine